Pulse Biosciences CCO Kevin P. Danahy resigns effective immediately

PULSE BIOSCIENCES, INC.

Kevin P. Danahy, Chief Commercial Officer, resigned effective February 27, 2026.
No reason for the resignation was disclosed in the filing.
No replacement has been named at this time.

item 5.02 item 9.01

PULSE BIOSCIENCES, INC. filing history →

Source: SEC EDGAR

accession 0001437749-26-006269

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.